waikeong179 Even China also approved Kangtai Biological's vaccine to be used, then very likely YT will be able to get a positive results!
==========
The issue is not the result as few already countries already approved. The concern is the 3000 volunteers, you only submit after compiling all 3000 vaccine trial data in Malaysia to NPRA. NPRA will take easily 3 months to access the data. All in all, it can take up to a year. Many trials failed not because of efficacy but not enough subject tested.
Why the need to delay with another unnecessary trial when China has done that and already rolling out the Kangtai vaccines to its people, and probably sending them out to countries in need. In a time of emergency like this, some procedures should be bypassed to save lives. Today Hishamuddin just said that too
So easy to say “unnecessary trial”? Imagine anything happened to Malaysian, I don’t know how many say unnecessarily trial one will F the government? Especially NPRA.
Or because you bought some Yong Tai share and you say unnecessarily?
sonickid, in fact even all WHO approved vaccines were for "emergency use" only. None have gone through the required human trial period as this pandemic have took too many lives. No denial that I've some YTB shares, but lives of families, friends & others were most important. I'd said the same for all other vaccines that could be procured asap & to be rolled out immediately to save lives & to prevent UNNECESSARY DEATHS. I believed the trials done in China were of utmost stringent and shall be recognized to save lives, time and resources
Maybe the point here is if YT capable to get another vaccine into Malaysia, out from so many medical organisation, it somehow shows that YT may have good up space for it's expansion in medical industry.
336699, yes non of the vaccines had gone thru all requirements compared standard protocol. That’s why it was still under emergency used. For your information, China is not the good place for trial as not enough Covid cases. You don’t study the efficacy rate in a place where not enough Covid cases. And I’m not saying YT vaccine can’t get emergency approval, just it may face greater difficulty
•*Property developer *Yong Tai Bhd* has announced that its subsidiary YTB Healthcare Sdn Bhd (YTBH) today received the first batch of an inactivated Covid-19 vaccine developed by China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT). The arrival of the vaccine followed the National Pharmaceutical Regulatory Agency granting its approval for the Clinical Trial Import License (CTIL) on June 3. This also enables YTBH to roll out the phase 3 clinical trial in Malaysia.
_*Disclaimer*:This message is for information purposes only. Reproduction or dissemination to third party is prohibited. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information nor shall it be construed as an offer/solicitation or recommendation to buy/sell any stocks . Investors should make their own informed decisions by consulting your own independent adviser(s) before investing. We accept no responsibility or liability for loss or damage that may arise from the reliance of this message. For the full information regarding the stocks mentioned herein please refer to the relevant websites._
透過 "YongTai Berhad (7066) vs Best Buy & Best Sell Basic Data Analysis" 裡頭的 09:40am 數據顯示,必須要有至少 5.4 millions 的資金湧入,或在資金湧入準備拉升的同時,相關 Best Sell 的主力掛盤同步被抽離,這樣才有機會在今日內衝破 0.30.
Kuala Lumpur: Pihak Berkuasa Kawalan Dadah (PBKD) memberi kelulusan pendaftaran bersyarat untuk kegunaan semasa bencana bagi dua produk vaksin yang memerlukan hanya satu dos pelalian iaitu Convidecia Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) dan Janssen Covid-19 Vaccine.
Ketua Pengarah Kesihatan Tan Sr Dr Noor Hisham Abdullah berkata, keputusan itu dicapai dalam Mesyuarat PBKD kali ke-359 yang bersidang, hari ini.
Menurutnya, produk itu adalah keluaran CanSino Biologics Inc di China iaitu pemegang pendaftaran produk, selain Solution Biologics Sdn Bhd dan Johnson & Johnson yang diberi kelulusan Penyenaraian Penggunaan Kecemasan (Emergency Use Listing atau EUL) oleh Pertubuhan Kesihatan Sedunia (WHO).
Katanya, pendaftaran Janssen Covid-19 Vaccine diperolehi oleh kerajaan Malaysia melalui fasiliti program pengedaran vaksin antarabangsa (Covax) yang dilaksanakan melalui mekanisme perakuan ke atas kelulusan WHO EUL.
"Selain itu, PBKD turut meluluskan penggunaan vaksin Comirnaty keluaran Pfizer-BioNTech kepada golongan yang berusia 12 tahun dan ke atas
"Comirnaty, sebelum ini diluluskan pendaftaran bersyarat pada 8 Januari lalu digunakan bagi tujuan imunisasi aktif kepada individu yang berusia 18 tahun dan ke atas," katanya dalam kenyataan media, hari ini.
Dr Noor Hisham berkata, walaupun tambahan indikasi itu sudah diluluskan, Kementerian Kesihatan Malaysia (KKM) berpandangan keutamaan pemberian vaksin kepada kumpulan berisiko tinggi selaras dengan dasar sedia ada yang ditetapkan di bawah Program Imunisasi Covid-19 Kebangsaan (PICK).
Menurutnya, kelulusan pendaftaran bersyarat itu memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin terbabit dipantau dan dinilai berdasarkan data terkini dari semasa ke semasa.
"Ia bagi memastikan perbandingan manfaat risiko (benefit over risk) bagi produk vaksin itu kekal positif.
"KKM akan sentiasa mempertingkatkan tahap kesihatan awam dalam memerangi wabak Covid-19 melalui perolehan bekalan vaksin yang sudah dinilai daripada aspek kualiti, keselamatan dan keberkesanan oleh Bahagian Regulatori Farmasi Negara (NPRA) dan diluluskan oleh PBKD.
"Kerajaan juga komited untuk memastikan penduduk Malaysia mencapai imuniti kelompok (herd immunity) selaras dengan sasaran PICK," katanya.
Fly???? With this kind of management at,better don hope..up 1 Sen for u maybe..haha..give u syiok sendiri…the kaput CEO :”do not compare yong Tai with solution eng”…because we r small company only….hahahahaha..
Opps…u r right! That y I never play long term esp this counter..buy lower sell when up few Sen..earn some Starbucks also nice….just pity those who stuck higher only..
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
keatdash73
135 posts
Posted by keatdash73 > 2021-06-13 09:42 | Report Abuse
how to register as volunteer ?